Concepedia

Author

Brett L. Carlson

Mayo ClinicORCID

Also Known As

B Carlson, B. Amendolara, B. CARLSON, B. Carlson, B. L. Carlson, B.L. Carlson, Barbara J Carlson, Brett Carlson, Brett L Carlson, Brett L. Carlson

267

Publications

5K

Citations

33

H-Index

42

Concepts

All Affiliations

Mayo ClinicWinnMedMayo Clinic in FloridaMayo Clinic in ArizonaUniversity of Minnesota
BL

About

Brett L. Carlson is an author at Mayo Clinic specializing in medicine, tumor biology, and glioma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

1.5K

2

Cell Biology

9

9

1.4K

3

Health Sciences

2

2

127

4

Cellular Physiology

1

1

12

5

Metabolism

1

1

12

Brett L. Carlson

×

52

Publications

4.9K

Citations

33

H-Index

YearCitations

Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts

Gaspar J. Kitange, Brett L. Carlson, Mark A. Schroeder,

Neuro-Oncology

2008

382

Patient tumor EGFR and PDGFRA gene amplificationsretained in an invasive intracranial xenograft model of glioblastomamultiforme

Caterina Giannini, Jann N. Sarkaria, Atsushi Saito,

Neuro-Oncology

2005

323

Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy

H.H. Sedlacek, Jörg Czech, Ramachandra Naik,

International Journal of Oncology

1996

277

Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response

Jann N. Sarkaria, Brett L. Carlson, Mark A. Schroeder,

Clinical Cancer Research

2006

276

Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.

Brett L. Carlson, Tyler Lahusen, Shradha Singh,

PubMed

1999

254

Establishment, Maintenance, and In Vitro and In Vivo Applications of Primary Human Glioblastoma Multiforme (GBM) Xenograft Models for Translational Biology Studies and Drug Discovery

Brett L. Carlson, Jenny L. Pokorny, Mark A. Schroeder,

Current Protocols in Pharmacology

2011

236

Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

Rachael A. Vaubel, Shulan Tian, Dioval Remonde,

Clinical Cancer Research

2019

223

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

Jann N. Sarkaria, Lin Yang, Patrick T. Grogan,

Molecular Cancer Therapeutics

2007

202

Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.

Jeffrey S. Eshleman, Brett L. Carlson, Ann C. Mladek,

PubMed

2002

200

p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

Ling Cen, Brett L. Carlson, Mark A. Schroeder,

Neuro-Oncology

2012

185

Page 1